Rolling Out44 分钟
Understanding age-related hearing loss
Learn about the causes of age-related hearing loss and discover effective strategies to manage presbycusis. Early ...
GlobalData on MSN2 天
Sensorion’s Phase I/II gene therapy trial to continue with DMC recommendation
Sensorion's Audiogene Phase I/II trial of the SENS-501 gene therapy programme has received a favourable recommendation from ...
Sensorion Announces Its Participation in Several Investor Conferences to be Held in March
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...
Frontiers5 天
Frontiers in Cellular Neuroscience
Direct effects of prolonged TNF-α and IL-6 exposure on neural activity in human iPSC-derived neuron-astrocyte co-cultures ...
Le Lézard5 天
Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501's ...
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss ...
Yahoo Finance2 天
Fennec Pharmaceuticals Inc. (FENC)
After hours: February 13 at 4:02:12 p.m. EST ...